About My Health Careers Internship MedBlogs Contact us

Target the Gene That Suppresses Autoimmune Diseases, Australian Scientists Say

by Gopalan on November 11, 2007 at 12:39 PM
Font : A-A+

Target the Gene That Suppresses Autoimmune Diseases, Australian Scientists Say

Research on treatment of autoimmune diseases should focus on the gene Roquin, say Australian researchers.

It was in 2005 Dr Carola Vinuesa and Professor Chris Goodnow from The Australian National University discovered that such pathologies were linked to the gene Roquin, which can undergo a specific mutation that results in it instructing T cells to react against the self. Now the researchers lead an international team that reports in the journal Nature on exactly how a healthy Roquin gene prevents abnormal T-cell behaviour.


The immune system is the body's front line of defence against disease-causing invaders such as bacteria, viruses and parasites.

However, sometimes this formidable defender can turn against us - mistakenly attacking and damaging the body's own tissues. This case of mistaken identity is the cause of common autoimmune diseases such as type one diabetes, rheumatoid arthritis and lupus.

The two researchers found that Roquin gene played a vital role in preventing the immune system from attacking friendly cells. It suppresses the production of antibodies that target the body's tissues, to keep us safe from our own molecular weaponry.

Antibodies are proteins normally produced by the body in response to infection or immunisation. They bind to pathogens, neutralising them or preparing them for destruction by other immune cells.

B-cells are the antibody factories of the immune system. When they recognise a potential pathogen they begin to multiply and produce antibodies to bind to their target. To do this however, they need assistance from helper T-cells that have also recognised the same potential pathogen.

Roquin specifically stops self-reactive T-cells from providing this assistance to B-cells, preventing the production of antibodies that might target healthy tissue. T-cells that react to invading pathogens are not suppressed by Roquin, allowing the immune system to mount a powerful defence against foreign threats without accidentally attacking friendly cells.

When a mutation causes Roquin to stop working, the immune system loses one of its safeguards against autoimmune diseases like lupus and diabetes.

"Our findings hinge on the fact that the activities of a normal Roquin gene are orchestrated by parts of the genome until very recently considered to be "junk DNA"," said Dr Vinuesa from the John Curtin School of Medical Research (JCSMR) at ANU.

The discovery centres on a form of RNA, or Ribo Nucleic Acid. Most RNAs are thought of as messengers that carry information from a cell's DNA blueprint so it can be written into proteins, the building-blocks of cells and tissues. But not all RNAs act as a messenger. Some small, non-protein-coding forms of the material, called microRNAs, actually induce the decay of messenger RNAs.

"This decay leads to reduction of the expression of proteins such as one called ICOS, that we have now shown can result in autoimmunity when it is over-expressed," said Dr Di Yu from JCSMR, who performed most of the experiments leading to the discovery. "This is the first time that microRNAs have been linked to protection from autoimmune diseases."

Once considered to be genetic junk, microRNAs are now thought to regulate up to 30 per cent of the genome, and have been recently shown to play an important role in the development of cancer and other diseases. "More and more scientists are beginning to think of genes as 'RNA factories'," said JCSMR's Professor Chris Goodnow, who is also the Director of the Australian Phenomics Facility at ANU. "We're learning more and more about how RNAs regulate critical processes related to cell development and the evolution of complex structures like the brain."

The researchers said their work opened up the possibility of using RNA interference, or the microRNAs themselves, in the treatment of autoimmune diseases.

Source: Medindia

News A-Z
News Category
What's New on Medindia
International Day of Persons with Disabilities 2021 - Fighting for Rights in the Post-COVID Era
Effect of Blood Group Type on COVID-19 Risk and Severity
Woman with Rare Spinal Cord Defect from Birth Sues Doctor
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
DNA Finger Printing Myasthenia Gravis Vitiligo Autoimmune Disorders Granulomatosis with Polyangiitis (GPA) Microscopic Polyangiitis Weaver Syndrome 

Recommended Reading
A comprehensive article on diabetes - both Type 1 and Type 2 diabetes, including : causes, signs, .....
Autoimmune Disorders
Autoimmune disorders occur when the immune system fails to recognize the body as ‘self’ and attacks ...
DNA Finger Printing
DNA fingerprinting is a technique which helps forensic scientists and legal experts solve crimes, id...
Granulomatosis with Polyangiitis (GPA)
Granulomatosis with Polyangiitis (GPA) is a type of vasculitis that usually affects the upper airway...
Microscopic Polyangiitis
Microscopic polyangitis, infection of small blood vessels, presents with general symptoms of fever, ...
Myasthenia Gravis
Myasthenia gravis is the commonest disorder of neuromuscular transmission. Autoimmune myasthenia gra...
Vitiligo is a skin disease characterized by patches of unpigmented skin. Vitiligo is usually slowly ...
Weaver Syndrome
Weaver syndrome is a genetic disorder in which children show accelerated bone growth, advanced bone ...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use